IL86302A0 - Pharmaceutical combination for the prophylaxis and therapy of malaria - Google Patents
Pharmaceutical combination for the prophylaxis and therapy of malariaInfo
- Publication number
- IL86302A0 IL86302A0 IL86302A IL8630288A IL86302A0 IL 86302 A0 IL86302 A0 IL 86302A0 IL 86302 A IL86302 A IL 86302A IL 8630288 A IL8630288 A IL 8630288A IL 86302 A0 IL86302 A0 IL 86302A0
- Authority
- IL
- Israel
- Prior art keywords
- malaria
- prophylaxis
- therapy
- pharmaceutical combination
- pharmaceutical
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873715378 DE3715378A1 (en) | 1987-05-08 | 1987-05-08 | COMBINATION OF MEDICINES ON PROPHYLAXIS AND THERAPY FROM MALARIA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL86302A0 true IL86302A0 (en) | 1988-11-15 |
Family
ID=6327117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL86302A IL86302A0 (en) | 1987-05-08 | 1988-05-06 | Pharmaceutical combination for the prophylaxis and therapy of malaria |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0290959A3 (en) |
| JP (1) | JPS6452714A (en) |
| KR (1) | KR880013558A (en) |
| AU (1) | AU614515B2 (en) |
| DE (1) | DE3715378A1 (en) |
| DK (1) | DK249688A (en) |
| HU (1) | HU200688B (en) |
| IL (1) | IL86302A0 (en) |
| IN (1) | IN166154B (en) |
| PT (1) | PT87427B (en) |
| ZA (1) | ZA883209B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4916204A (en) * | 1987-07-31 | 1990-04-10 | Massachusetts Institute Of Technology | Pure polyanhydride from dicarboxylic acid and coupling agent |
| NZ228748A (en) * | 1988-04-20 | 1991-07-26 | Merrell Dow Pharma | Treating drug-resistant protozoal infections with a tricyclic compound and an antiprotozoal agent: composition and kit therefor |
| ES2054975T3 (en) * | 1988-10-07 | 1994-08-16 | Hoechst Ag | ANTIMALARIC COMPOSITIONS USING QUINIDINE, ARTEMISININ AND ITS DERIVATIVES. |
| EP0535719A3 (en) * | 1988-12-06 | 1993-04-14 | Dermatologic Research Corporation | Treatment of hemorrhoids with artemisinin and derivates |
| EP0464233A1 (en) * | 1990-07-02 | 1992-01-08 | Hoechst Aktiengesellschaft | Pharmaceutical combinations against malaria |
| JP3560970B2 (en) * | 1992-02-07 | 2004-09-02 | ノバルティス アクチェンゲゼルシャフト | Antimalarial synergistic composition containing benzoflumetol |
| GB9622427D0 (en) * | 1996-10-28 | 1997-01-08 | Pharma Mar Sa | Antimalarial drugs |
| US6160004A (en) * | 1997-12-30 | 2000-12-12 | Hauser, Inc. | C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities |
| IN191696B (en) * | 1999-02-12 | 2003-12-20 | Council Scient Ind Res | |
| CN1210030C (en) * | 2000-03-28 | 2005-07-13 | 科学与工业研究委员会 | Antimicrobial composition and mthod for producing same |
| AU2001295979A1 (en) * | 2000-10-20 | 2002-04-29 | Ajinomoto Co., Inc. | Medicinal compositions, dose and method for treating malaria |
| CN1255106C (en) * | 2003-09-26 | 2006-05-10 | 李国桥 | Complex artemisia apiacea extract |
| WO2006070393A1 (en) * | 2004-12-28 | 2006-07-06 | Council Of Scientific And Industrial Research | SYNERGISTIC COMBINATION KIT OF α,ß-ARTEETHER, SULFADOXIN AND PYMETHAMINE FOR TREATMENT OF SEVERE/MULTI-DRUG RESISTANT CEREBRAL MALARIA |
| FR2884715B1 (en) * | 2005-04-20 | 2007-06-15 | Sanofi Aventis Sa | ASSOCIATION BETWEEN FERROQUIN AND AN ARTEMISININE DERIVATIVE FOR THE TREATMENT OF MALARIA |
| WO2007043061A1 (en) * | 2005-10-11 | 2007-04-19 | Ipca Laboratories Ltd. | Anti-malarial combination and methods of formulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ228748A (en) * | 1988-04-20 | 1991-07-26 | Merrell Dow Pharma | Treating drug-resistant protozoal infections with a tricyclic compound and an antiprotozoal agent: composition and kit therefor |
| ES2054975T3 (en) * | 1988-10-07 | 1994-08-16 | Hoechst Ag | ANTIMALARIC COMPOSITIONS USING QUINIDINE, ARTEMISININ AND ITS DERIVATIVES. |
-
1987
- 1987-01-29 IN IN26/BOM/87A patent/IN166154B/en unknown
- 1987-05-08 DE DE19873715378 patent/DE3715378A1/en not_active Withdrawn
-
1988
- 1988-05-05 ZA ZA883209A patent/ZA883209B/en unknown
- 1988-05-05 EP EP88107223A patent/EP0290959A3/en not_active Withdrawn
- 1988-05-06 DK DK249688A patent/DK249688A/en unknown
- 1988-05-06 PT PT87427A patent/PT87427B/en not_active IP Right Cessation
- 1988-05-06 JP JP63109239A patent/JPS6452714A/en active Pending
- 1988-05-06 AU AU15675/88A patent/AU614515B2/en not_active Ceased
- 1988-05-06 IL IL86302A patent/IL86302A0/en unknown
- 1988-05-06 HU HU882314A patent/HU200688B/en not_active IP Right Cessation
- 1988-05-07 KR KR1019880005305A patent/KR880013558A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT87427A (en) | 1989-05-31 |
| EP0290959A3 (en) | 1990-03-07 |
| DE3715378A1 (en) | 1988-11-24 |
| DK249688A (en) | 1988-11-09 |
| IN166154B (en) | 1990-03-24 |
| HUT47846A (en) | 1989-04-28 |
| AU1567588A (en) | 1988-11-10 |
| AU614515B2 (en) | 1991-09-05 |
| KR880013558A (en) | 1988-12-21 |
| HU200688B (en) | 1990-08-28 |
| DK249688D0 (en) | 1988-05-06 |
| PT87427B (en) | 1992-09-30 |
| JPS6452714A (en) | 1989-02-28 |
| EP0290959A2 (en) | 1988-11-17 |
| ZA883209B (en) | 1988-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2204237B (en) | Agents for the prophylaxis and therapy of retroviral infections | |
| EP0491861A4 (en) | Prophylaxis and therapy of acquired immunodeficiency syndrome | |
| CS403391A3 (en) | Pharmaceutical | |
| GB8716133D0 (en) | Treatment of materials | |
| NZ226002A (en) | Peptidylheterocyclic compounds and pharmaceutical compositions | |
| AU2914889A (en) | Prophylaxis and therapy of acquired immunodeficiency syndrome | |
| IL86302A0 (en) | Pharmaceutical combination for the prophylaxis and therapy of malaria | |
| EP0304802A3 (en) | Pharmaceutical composition and the use thereof | |
| NZ226450A (en) | Crystalline-1-carbacephalosporin and pharmaceutical compositions | |
| PH23235A (en) | Combination preparations for the treatment of malaria | |
| NZ225613A (en) | Benzazepin-2-one derivatives and pharmaceutical compositions | |
| GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
| EP0400075A4 (en) | Enhancement of the therapeutic properties of glycoprotein | |
| GB8712240D0 (en) | Pharmaceutical formulation | |
| GB8911551D0 (en) | Treatment of pastures | |
| EP0305902A3 (en) | Medicament | |
| IL88566A (en) | Composition for the reduction of phlebectasiae and its preparation | |
| IL86116A0 (en) | Pharmaceutical compositions for the treatment of malaria | |
| ZA882667B (en) | Agents for the prophylaxis and therapy of retroviral infections | |
| GR871526B (en) | Medicine for fighting the psoriasis and the eczema | |
| RO92740B1 (en) | Medicinal composition for the treatment of otites | |
| IE872788L (en) | Pharmaceutical combination | |
| GB8727005D0 (en) | Administration of pharmaceutical products | |
| GB8719374D0 (en) | Pharmaceutical devices | |
| NZ221377A (en) | Diselenobis benzamides and pharmaceutical compositions |